Results 241 to 250 of about 19,955 (310)

Urinary Diversion–Specific Morbidity After Radical Cystectomy: A Ten‐Year Institutional Experience

open access: yesCancer Medicine, Volume 15, Issue 3, March 2026.
ABSTRACT Introduction This study investigates the correlations and risk factors of complications associated with different urinary diversion methods after radical cystectomy (RC) for bladder cancer (BC). Methods A retrospective analysis was conducted on 574 bc patients treated between 2012 and 2022.
Xuanhan Hu   +8 more
wiley   +1 more source

Systematic Review of Genomic‐Based Risk Stratification in Localised Prostate Cancer Treatment Optimisation: Clinical Impact and Health Economic Evidence

open access: yesCancer Medicine, Volume 15, Issue 3, March 2026.
ABSTRACT Background Several genomic risk stratification tests are available to predict the risk of metastasis and mortality for prostate cancer patients at the time of diagnosis. However, the evidence supporting the clinical utility of genomic risk stratification tools is fragmented, posing challenges in assessing their real‐world clinical impact and ...
Juntao Lyu   +4 more
wiley   +1 more source

Pattern and Clinical Significance of CA19‐9 Expression in Human Cancer: A Tissue Microarray Study on 14,966 Tumors

open access: yesCancer Medicine, Volume 15, Issue 3, March 2026.
ABSTRACT Background Carbohydrate antigen 19–9 (CA19‐9) is a cell surface glycoprotein widely used as a diagnostic and prognostic serum marker for monitoring pancreatic cancer. The aim of this study was to evaluate the prevalence and clinical relevance of CA19‐9 expression in human cancer. Methods To comprehensively determine the prevalence and clinical
Nina Schraps   +31 more
wiley   +1 more source

Impact of Perioperative Proton Pump Inhibitors on Renal Cancer Progression. A Retrospective Study

open access: yesCancer Medicine, Volume 15, Issue 3, March 2026.
ABSTRACT Background Clear cell renal cell carcinoma (ccRCC) is the most common kidney cancer. Metastatic disease causes most deaths. We investigated the association between ATP4A gene status and survival following nephrectomy. ATP4A encodes H+/K+ ATPase, targeted by proton pump inhibitors (PPIs).
Nicolas Cortes‐Mejia   +6 more
wiley   +1 more source

The Use of Artificial Intelligence in Urologic Oncology: Current Insights and Challenges. [PDF]

open access: yesRes Rep Urol
Cicchetti R   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy